title: Nivolumab: another weapon in the growing immunotherapy arsenal.
authors: Sarah Cannon Research Institute at HealthONE, Denver, CO 80218, USA. Electronic address: gerald.falchook@scresearch.net.
authors: Gerald
authors: G
authors: Falchook
mesh_terms: D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage*; D064420:Drug-Related Side Effects and Adverse Reactions / Q000473:pathology*; D005260:Female; D006801:Humans; D008297:Male; D008545:Melanoma / Q000188:drug therapy*
chemical_list: D000911:Antibodies, Monoclonal